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INTRODUCTION
Menopause is the cessation of the monthly hormonal cycle
in adult women, and it results in decreasing estrogen levels
and a lack of menstruation. Without folliculogenesis, the
cystic activity in the ovary ceases. More than 80% of ovarian
cancer occurs in women over the age of 50 yr. Older women
are more likely to present with advanced disease, and their
relative 5-yr survival rates are less than half of that for women
that are under the age of 65 yr (1). The presence of even a
relatively simple ovarian cyst in the postmenopausal woman
is considered as ominous.
The standard operative approach for postmenopausal adnex-
al masses, whether they are detected by manual or ultrasound
examination, has been exploratory laparotomy to rule out the
possibility of ovarian malignancy (1). This approach has been
adopted even though most adnexal cystic masses in these
women are benign (2, 3). Operative laparoscopic techniques,
because of their safety and efficacy, have been suggested as
an alternate approach to open surgery for the treatment of
adnexal masses in pre- and postmenopausal women (4, 5).
Several researchers have claimed that ultrasound can accu-
rately predict benign cystic masses in the majority of post-
menopausal women (6-8). Various sonomorphologic scoring
systems that assign numerical ultrasonographic parameters
to adnexal tumors have been developed in order to differen-
tiate between benign and malignant neoplasms in pre- and
postmenopausal women (9). Sassone et al. have assigned four
morphologic characteristics to adnexal masses (inner wall
structure, wall thickness, characteristics of the septa and echo-
genicity) according to the likelihood of finding a malignant
tumor (8). Our center has used this scoring system for ultra-
sonography in all our patients to identify the malignant fea-
tures of adnexal masses.
In addition, CA-125 is a commonly used tumor marker to
differentiate benign masses from malignant adnexal masses,
and it is also used for follow-up of patients with ovarian can-
cer. Serum CA-125 values are elevated in different gyneco-
logic and nongynecologic cancers, and also for some benign
conditions. The reference value of 35 IU/mL was based on the
pioneering work by Bast et al. (10) who have reported that
only 1% of apparently healthy women and 6.3% of women
with benign disease had values above that level. As the ref-
erence value of CA-125 rises, the specificity and predictive
value of CA-125 increases (11, 12). It is generally believed
that the greater the CA-125 value, the greater the probability
that an abdominopelvic mass is cancer (13). Bast et al. (10)
have demonstrated that as the reference value increased to
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Selected Adnexal Cystic Masses in Postmenopausal Women Can be
Safely Managed by Laparoscopy
The aim of this study was to assess the efficacy and safety of laparoscopic treat-
ment for adnexal cystic masses that were predicted to be benign in postmenopausal
women. Postmenopausal women found to have an adnexal cystic mass were ret-
rospectively evaluated with transvaginal ultrasonography, and serum CA-125 levels.
The selection criteria were adnexal cystic masses greater than 3 cm but less than
10 cm, the masses were in the benign range (4-8) of Sassone’s scoring system for
transvaginal ultrasonography, and the patients had serum CA-125 levels less than
65 IU/mL. Two hundred nineteen women fulfilled the criteria and underwent oper-
ative laparoscopy. Almost all the masses (99.5%) were accurately predicted to be
benign except for one borderline ovarian tumor. Two hundreds thirteen (97.3%)
women were successfully managed by operative laparoscopy and six (2.7%) required
laparotomy. For the patients managed by laparoscopy, the mean operative time
was 51.3 min; the mean hospital stay was 2.5 days. There was no significant mor-
bidity and surgery-related mortality. The combination of the Sassone’s scoring sys-
tem for transvaginal ultrasonography and serum CA-125 level can accurately pre-
dict benign cystic masses, and operative laparoscopy is technically feasible and safe
for the management of adnexal mass in postmenopausal women.
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65 IU/mL, the number of apparently healthy women decreased
to 0.2% and the number of patients with benign disease de-
creased to 2.1%. The specificity at the cutoff serum level of
35 IU/mL is low and therefore, this test is probably followed
by a number of unnecessary tests and finally by interventions
for patients with an endometrial or inflammatory adnexal
tumor. At the level of 65 IU/mL, the specificity is high and
for these patients having a high level, only a few unnecessary
tests and interventions might be undertaken (14).
Current research now involves defining the criteria that will
aid surgeons in selecting those postmenopausal patients who
are likely to have benign cystic masses. In this study, we have
combined Sassone’s scoring system for transvaginal ultrasound
and a serum CA-125 assay (using 65 IU/mL as a cutoff level)
for the preoperative selection of postmenopausal women likely
to have benign adnexal cystic masses. We have also evaluated
the effectiveness and safety of laparoscopic management of
adnexal cystic masses in postmenopausal women.
MATERIALS AND METHODS
We retrospectively evaluated the hospital records of all
consecutive patients over the age of 47 yr at the Department of
Obstetrics and Gynecology, Samsung Medical Center, Sung-
kyunkwan University School of Medicine from January 1996
to May 2004 that had a preoperative diagnosis of adnexal
cystic mass, and whose surgery was done laparoscopically.
Postmenopausal status was defined as a woman older than
47 yr of age with at least 12 months of amenorrhea. All the
postmenopausal women underwent a transvaginal examina-
tion within 6 weeks of their operation. Patients were selected
on the basis of preoperative clinical examination, transvagi-
nal ultrasonography and a serum level of CA-125. The indi-
cations for laparoscopic surgery were: 1) adnexal cystic masses
in the benign range (4-8) of Sassone’s scoring system for trans-
vaginal ultrasonography (8); 2) lesions larger than 3 cm but
less than 10 cm; 3) a serum level of CA-125 less than 65 IU/
mL. All procedures were performed solely by the surgeons
from the Division of Gynecologic Oncology, Samsung Medi-
cal Canter. Preoperatively, all patients understood and were
informed of the need for possible laparotomy or other indi-
cated procedures. Initially, upon visualization of the abdomen
and pelvis, any fluid that was present was aspirated and sent
for cytology. Next, a thorough evaluation was made of the
pelvis and abdomen including the adnexa, peritoneal surfaces,
liver, diaphragm, omentum and paracolic gutters, and any
suspicious or abnormal-appearing areas were biopsied and
sent to the pathology lab. All adnexal masses were placed
into synthetic bags and subsequently removed through the
suprapubic port to avoid intraperitoneal spillage of the sur-
gical specimen and contamination of the abdominal wall
during the removal process. If spillage did occur, thorough
irrigation with sodium chloride or Ringer’s lactate solution
was carried out. Bleeding was controlled by unipolar or bipo-
lar coagulation forceps, or sutures, as was appropriate. Sus-
pected malignancies of the adnexa masses were sent for ‘frozen’
pathological examination at the time of the operation. If no
malignancy was detected, no further evaluation was done. As
a rule, any sign of malignancy demanded exploratory laparo-
tomy with complete tumor staging.
RESULTS
Operative laparoscopy was performed on 219 consecutive
patients. The demographic characteristics of the postmeno-
pausal women that were enrolled in our study are depicted
in Table 1. Cesarean section was the most common previous
history of abdominal operation, and this was followed by ap-
pendectomy, adnexectomy, tubal ligation, hysterectomy and
nephrectomy, and the underlying medical diseases were most
often hypertension, diabetes, thyroid disease, asthma, heart
disease and renal disease. Laparoscopic management included,
in the order of frequency, adnexectomy, oophorectomy, cys-
tectomy and salpingectomy which was successful for 213
(97.3%) patients. Cystectomy was performed only for paratu-
bal or paraovarian cyst. Among the 6 patients requiring lapa-
rotomy, five (83.3%) cases were converted electively at the
Characteristics Results
Age (yr) 59.1±6.80* (47.3-76.1)
Years past menopause 8.7±7.32* (1.0-33.2)
Symptoms at presentation
Asymptomatic 151 (68.9%)
Abdominal pain or discomfort 36 (16.4%)
Vaginal bleeding or discharge 13 (5.9%)
Palpable abdominal mass 5 (2.3%)
Other 14 (6.4%)
Operative times (min) 51.3±27.5* (15-275)
Hospital days 2.5±0.65* (1-8)
Tumor size (cm) 5.68±2.08* (3-10)
Previous abdominal surgery 64 (29.2%)
Underlying medical disease 71 (32.4%)
Table 1. Demographic data
*Values are mean±SD.
Histologic types No. of cases (%)
Serous cystadenoma 103 (47.0)
Mucinous cystadenoma 37 (16.9)
Mature cystic teratoma 40 (18.3)
Endometrioma 7 (3.2)
Paraovarian or paratubal cysts 21 (9.6)
Hydrosalpinx 5 (2.3)
Borderline malignancy 1 (0.5)
Other 5 (2.3)
Total 213 (100.0)
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discretion of the operating surgeon, and one (16.7%) case was
converted based on the frozen section reports indicating a bor-
derline ovarian malignancy that required staging laparotomy.
Of the five cases electively converted to laparotomy, all these
were due to the anticipated technical difficulties encountered
because of extensive pelvic or extrapelvic adhesions.
The serum CA-125 levels were measured in all patients,
and 10 (5.4%) patients had values between 35 and 65 IU/mL.
The pathologic types of adnexal masses are shown in Table 2.
Most of the adnexal masses were, in the order of frequency,
serous cystadenoma, mature cystic teratoma, and mucinous
cystadenoma. Among these 219 cases, one borderline ovarian
malignancy was discovered on the frozen sections. The patient
was 61 yr old and had a 5.5 cm-sized cystic mass in her right
ovary with a normal CA-125 level (31.4 IU/mL). She also
had surgical staging performed for ovarian malignancy and
this revealed a borderline malignancy of serous cystadenoma
on the permanent biopsy.
Intraoperative complications occurred in two patients due
to bleeding from the secondary trocar entry site. Postoperative
complications occurred in four patients due to superficial
abdominal hematoma and a decrease in hemoglobin levels,
but only one patient required a blood transfusion. There was
no surgery-related mortality.
DISCUSSION
The aim of the current study was to evaluate the efficacy and
safety of laparoscopic treatment for postmenopausal women
with adnexal cystic masses that were predicted to be benign.
The selection criteria used in this study were a combination
of the Sassone’s scoring system for transvaginal ultrasonog-
raphy and the serum CA-125 level, and this combined cri-
teria accurately predicted benign mass in most postmeno-
pausal women (99.5%) except for only one patient who had
a borderline ovarian malignancy. The laparoscopy was suc-
cessfully completed in 213/219 (97.3%) patients without
the need to proceed with laparotomy. Laparoscopic surgery
for postmenopausal women resulted in shorter operative times
and hospital stays compared to the conventional laparotomy
procedure, and a history of previous abdominal surgery and
underling medical diseases did not influence the success of
laparoscopic surgery in these postmenopausal women.
With appropriate preoperative evaluation, laparoscopic
surgery is well-known to be technically feasible, safe and advan-
tageous with minimal morbidity, and this minimally inva-
sive procedure could replace laparotomy for the management
of most adnexal cystic masses occurring during the reproduc-
tive years (15-17). However, until now, the laparoscopic man-
agement of postmenopausal patients found to have an adnexal
mass was controversial, although appropriate patient selec-
tion might be the critical factor for the successful application
of this recently developed procedure.
The preoperative assessment by sonography for the size
and consistency of an adnexal mass has been studied to deter-
mine the probability of malignancy (9). Most adnexal masses
are benign (18), however, numerous studies have examined
whether the gray-scale or Doppler sonographic criteria can
allow for distinction between benign and malignant ovarian
masses. When reviewing the entirety of the relevant litera-
ture, the studies indicate that no single gray-scale or Doppler
sonographic feature allows for reliable distinction between
benignity and malignancy. Despite the extensive literature
on the subject that has been generated, the choice of which
sonographic feature(s) to use, and in particular the role of
Doppler sonography in predicting malignancy, remains con-
troversial. Although most comparison studies have found
gray-scale sonography to be superior to Doppler sonography
(19-21), or that Doppler sonography offers no significant
improvement over gray-scale sonography (22-24), a minority
of studies have reported the Doppler features to be superior
(25, 26). The Sassone’s scoring system for ultrasonography
used in our current study is a sonographic-morphological
evaluation of adnexal masses using parameters such as the
presence of papillary protrusions, solid parts, thick septa and
high echogenic reflection patterns (8). These tumor morphology
scores vary from 4 to 15, and a score of 9 was used to distin-
guish benign lesions from malignant tumors. Using a mor-
phology score ≥9 as being indicative of cancer, malignant
ovarian tumors were distinguished from benign lesions with
a specificity of 83%, a sensitivity of 100%, a positive predic-
tive value of 37% and negative predictive value of 100% (8).
This scoring system seems to be extremely useful in assessing
the risk of ovarian malignancy in postmenopausal women
with adnexal cystic masses, and we have demonstrated this
with the excellent results of our study.
Moreover, when we used the cutoff level of CA-125 as 65
IU/mL, there were 10 patients with the values between 35
and 65 IU/mL. In fact, the CA-125 level of one patient with
borderline ovary tumor was below 35 IU/mL. As a result, the
poor sensitivity and specificity of CA-125 limits its use as a
sole screening test for early ovarian cancer. However, when
the CA-125 level is elevated in association with an abnormal
sonographic finding, and particularly in a postmenopausal
woman, there should be a high index of suspicion for the pres-
ence of ovarian malignancy (9).
Several studies have reported on the safety and effectiveness
of laparoscopic adnexectomy in postmenopausal women by
using the selection criteria of ultrasonography and serum
levels of CA-125. There was one study done on postmenopausal
women having selection criteria for laparoscopy that included
ovarian cysts that did not meet the criteria of a simple cyst,
cysts were larger than 4 cm and had a pathological Doppler
flow, or there was an elevated CA-125 level; all the laparo-
scopies were successfully accomplished and no cases of malig-
nancy were found (27). In another study, when the adnexal
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ance were found to be other than a complex cyst, and this was
paired with a normal serum CA-125 level, laparoscopic bilat-
eral oophorectomy was performed in all 55 postmenopausal
women and all the lesions were benign masses (28). There was
another prospective multi-center study in which the selection
criteria for the study were an adnexal mass evaluated with
clinical examination, sonography, and CA-125 levels. The
specific criteria included cystic masses greater than 3 cm but
less than 10 cm, the masses had to have distinct borders with-
out solid parts or septations greater than 2 mm, the patients
were without ascites or matted bowel, and the serum CA-125
levels were less than 35 IU/mL. The final result was that all
of the masses in the 61 postmenopausal women were accu-
rately predicted to be benign (29). In this regard, we consid-
ered preoperative ultrasound examination and serum CA-125
level to be of utmost importance. Intraoperative frozen sec-
tion examination is extremely helpful, although both sam-
pling and judgment errors can and do occur in large border-
line mucinous tumors (30).
In conclusion, by careful selection of patients using the
Sassone’s scoring system for transvaginal ultrasonography
and the serum CA-125 assay (with 65 IU/mL as the cutoff
level), laparoscopic management for postmenopausal adnexal
cystic masses can be performed safely without fear of misdi-
agnosing the incidental malignant neoplasm, and this treat-
ment method is technically feasible and safe with minimal
morbidity.
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